Download PDF
Am J Perinatol 2023; 40(01): 095-098
DOI: 10.1055/s-0041-1728833
Original Article

Massive Transfusion Protocols in Obstetric Hemorrhage: Theory versus Reality

Bahram Salmanian
1   Depatment of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas
,
Steven L. Clark
1   Depatment of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas
,
Shiu-Ki R. Hui
2   Depatment of Pathology and Immunology, Baylor College of Medicine, Houston, Texas
,
Sarah Detlefs
1   Depatment of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas
,
Soroush Aalipour
1   Depatment of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas
,
Nazlisadat Meshinchi Asl
1   Depatment of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas
,
Alireza A. Shamshirsaz
1   Depatment of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Objective Massive transfusion protocols are widely implemented in obstetrical practice in case of severe hemorrhage; however, different recommendations exist regarding the appropriate ratios of blood product components to be transfused. We report our extensive experience with massive component transfusion in a referral center in which the standard massive transfusion protocol is modified by ongoing clinical and laboratory evaluation.

Study Design A retrospective chart review of all patients who had massive transfusion protocol activation in a level 4 referral center for obstetrical practice was performed from January 2014 to January 2020. Data collected included the etiology of obstetrical hemorrhage, number of blood products of each type transfused, crystalloid infusion, and several indices of maternal morbidity and mortality. Data are presented with descriptive statistics.

Results A total of 62 patients had massive transfusion protocol activation, of which 97% received blood products. Uterine atony was found to be the most common etiology for massive hemorrhage (34%), followed by placenta accreta spectrum (32%). The mean estimated blood loss was 1,945 mL. A mean of 6.5 units of packed red blood cells, 14.8 units of fresh frozen plasma and cryoprecipitate, and 8.3 units of platelets were transfused per patient. No maternal deaths were seen.

Conclusion The ratios of transfused packed red blood cell to fresh frozen plasma/cryoprecipitate and of packed red blood cell to platelet units varied significantly from the fixed initial infusion ratio called for by our massive transfusion protocol resulting in universally favorable maternal outcomes. When rapid laboratory evaluation of hematologic and clotting parameters is available, careful use of this information may facilitate safe modification of an initial fixed transfusion ratio based on etiology of the hemorrhage and individual patient response.

Key Points

  • Massive transfusion protocols in obstetrics follow fixed ratios of blood products.

  • Actual usage of blood components is different than the standardized protocols.

  • We recommend to modify the initial fixed transfusion ratio according to clinical response.

Keywords

obstetric hemorrhage - postpartum hemorrhage - massive transfusion


Publication History

Received: 27 August 2020

Accepted: 02 March 2021

Article published online:
14 May 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Clark SL, Christmas JT, Frye DR, Meyers JA, Perlin JB. Maternal mortality in the United States: predictability and the impact of protocols on fatal postcesarean pulmonary embolism and hypertension-related intracranial hemorrhage. Am J Obstet Gynecol 2014; 211 (01) 32.e1-32.e9
    CrossrefPubMedGoogle Scholar
  • 2 Clark SL. Obstetric hemorrhage. Semin Perinatol 2016; 40 (02) 109-111
    CrossrefPubMedGoogle Scholar
  • 3 Tanaka H, Matsunaga S, Yamashita T. et al. A systematic review of massive transfusion protocol in obstetrics. Taiwan J Obstet Gynecol 2017; 56 (06) 715-718
    CrossrefPubMedGoogle Scholar
  • 4 Pacheco LD, Saade GR, Costantine MM, Clark SL, Hankins GD. An update on the use of massive transfusion protocols in obstetrics. Am J Obstet Gynecol 2016; 214 (03) 340-344
    CrossrefPubMedGoogle Scholar
  • 5 Kogutt BK, Vaught AJ. Postpartum hemorrhage: Blood product management and massive transfusion. Semin Perinatol 2019; 43 (01) 44-50
    CrossrefPubMedGoogle Scholar
  • 6 Holcomb JB, Wade CE, Michalek JE. et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008; 248 (03) 447-458
    CrossrefPubMedGoogle Scholar
  • 7 Pacheco LD, Saade GR, Gei AF, Hankins GD. Cutting-edge advances in the medical management of obstetrical hemorrhage. Am J Obstet Gynecol 2011; 205 (06) 526-532
    CrossrefPubMedGoogle Scholar
  • 8 Guerado E, Medina A, Mata MI, Galvan JM, Bertrand ML. Protocols for massive blood transfusion: when and why, and potential complications. Eur J Trauma Emerg Surg 2016; 42 (03) 283-295
    CrossrefPubMedGoogle Scholar
  • 9 Hess JR, Ramos PJ, Sen NE. et al. Quality management of a massive transfusion protocol. Transfusion 2018; 58 (02) 480-484
    CrossrefPubMedGoogle Scholar
  • 10 Kepley JM, Mohiuddin SS. Physiology, Maternal Changes. StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2020
    Google Scholar
  • 11 Erez O. Disseminated intravascular coagulation in pregnancy: clinical phenotypes and diagnostic scores. Thromb Res 2017; 151 (Suppl. 01) S56-S60
    CrossrefPubMedGoogle Scholar
  • 12 Erez O, Mastrolia SA, Thachil J. Disseminated intravascular coagulation in pregnancy: insights in pathophysiology, diagnosis and management. Am J Obstet Gynecol 2015; 213 (04) 452-463
    CrossrefPubMedGoogle Scholar
  • 13 Margarido C, Ferns J, Chin V. et al. Massive hemorrhage protocol activation in obstetrics: a 5-year quality performance review. Int J Obstet Anesth 2019; 38: 37-45
    CrossrefPubMedGoogle Scholar